MIRA INFORM REPORT
|
Report Date : |
21.04.2008 |
IDENTIFICATION
DETAILS
|
Name : |
TAKSAL PHARMA PRIVATE LIMITED |
|
|
|
|
Registered Office : |
9 – 10/3 Ground Floor, Laxman House, Asaf Ali Road, New Delhi - 110002 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2007 |
|
|
|
|
Date of Incorporation : |
31.10.2002 |
|
|
|
|
Com. Reg. No.: |
55-117553 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24231DL2002PTC117553 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
DELT04154D |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AAACT0403F |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Importer and Trader of Life Saving Drugs Medicines |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 170000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is well established and reputed company having fine track. Trade
relations are fair. Financial position is good. Payments are usually correct
and as per commitment. The company is doing well. It can be considered good for any normal business dealings at usual
trade terms and conditions. |
LOCATIONS
|
Registered Office : |
9 – 10/3 Ground Floor, Laxman House, Asaf Ali Road, New Delhi –
110002, India |
|
Tel. No.: |
91-11-23240071-74 / 30128001-4 |
|
Fax No.: |
91-11-23240075 |
|
E-Mail : |
|
|
|
|
|
Corporate Office : |
16/1, 1st Floor, Doctor’s lane, Gole Market, Delhi –
110001, India |
|
Tel. No.: |
91-11-23746036 |
|
Fax No.: |
91-11-23746055 |
DIRECTORS
|
Name : |
Mr. Vijay Dhar |
|
Designation : |
Director |
|
Address : |
178, Golf Link New Delhi -110003 |
|
Date of Birth/Age : |
18.05.1941 |
|
Date of Appointment : |
31.10.2002 |
|
|
|
|
Name : |
Lt Kuldeep Kumar Mehra |
|
Designation : |
Additional Director |
|
Address : |
A – 204, Som Vihar, R. K. Puram, Delhi – 110022, India |
|
Date of Birth/Age : |
13.06.1934 |
|
Date of Appointment : |
16.06.2006 |
|
|
|
|
Name : |
Mr. Vikas Dhar |
|
Designation : |
Whole time Director |
|
Address : |
178 ,Golf Link, New Delhi-110003 |
|
Date of Birth/Age : |
16.04.1967 |
|
Date of Appointment : |
24.09.2003 |
|
|
|
|
Name : |
Mr. Gopi Dargan |
|
Designation : |
Director |
|
Address : |
C – 6/54, Safdarjung, Development Area, Delhi – 110016, India |
|
Date of Birth/Age : |
15.07.1942 |
|
Date of Appointment : |
31.10.2002 |
|
Date of Ceasing : |
06.01.2005 |
|
|
|
|
Name : |
Mr. Kulbhushan Kumar Mehta |
|
Designation : |
Director |
|
Address : |
D – 108, Sector 40, Noida – 201301, Uttar Pradesh, India |
|
Date of Birth/Age : |
03.09.1935 |
|
Date of Appointment : |
24.11.2005 |
KEY EXECUTIVES
|
Name : |
Mr. Sanjeev Gupta |
|
Designation : |
Company Secretary |
|
Address : |
306, Sasco Bhawana, Commercial Complex, Azadpur, Delhi -110033 |
|
Tel No. : |
91-11-27677299 |
|
Mobile No. : |
91-9810079135 / 9810015102 |
|
E Mail : |
MAJOR SHAREHOLDERS
/ SHAREHOLDING PATTERN
As on 31.03.2007
|
Names of Shareholders |
|
No. of Shares |
|
Vijay Dhar |
|
650000 |
|
Sunanda Dhar |
|
230000 |
|
Vishal Dhar |
|
120000 |
|
Total |
|
1000000 |
Equity Share breakup ( Percentage of total equity) [As on 30.09.2007]
|
Category |
|
Percentage of
Holding |
|
|
|
|
|
Directors or relatives of directors |
|
100.00 |
|
|
|
|
BUSINESS DETAILS
|
Line of Business : |
Importer and Trader of Life Saving Drugs Medicines |
GENERAL
INFORMATION
|
No. of Employees : |
100 |
|
|
|
|
Bankers : |
Standard Chartered Bank Narain Manzil, 23, Barakhamba Road, New Delhi – 110001, India |
|
|
|
|
Banking
Relations : |
Satisfactory |
|
|
|
|
Auditors : |
|
|
Name : |
Dinesh Mehta and Company Chartered Accountants |
|
Address : |
21, Daya Nand Road, Darya Ganj, New Delhi 110002 |
CAPITAL STRUCTURE
AS ON 10.09.2007
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
5000000 |
Equity Shares |
Rs. 10/- each |
Rs. 50.000 Millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
1000000 |
Equity Shares |
Rs. 10/- each |
Rs. 10.000 Millions |
FINANCIAL DATA
[all figures are in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
10.000 |
0.500 |
0.500 |
|
|
2] Share Application Money |
0.000 |
0.00 |
0.00 |
|
|
3] Reserves & Surplus |
32.227 |
26.185 |
18.946 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
42.227 |
26.685 |
19.446 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.589 |
00.000 |
00.000 |
|
|
2] Unsecured Loans |
0.000 |
00.000 |
00.000 |
|
|
TOTAL BORROWING |
0.589 |
00.000 |
00.000 |
|
|
DEFERRED TAX LIABILITIES |
0.149 |
0.157 |
0.242 |
|
|
|
|
|
|
|
|
TOTAL |
42.965 |
26.842 |
19.688 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
11.743 |
5.883 |
3.123 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
695.817
|
246.265
|
181.792 |
|
|
Sundry Debtors |
265.935
|
187.120
|
97.044 |
|
|
Cash & Bank Balances |
161.108
|
146.729
|
101.168 |
|
|
Other Current Assets |
0.000
|
0.000
|
0.000 |
|
|
Loans & Advances |
129.179
|
85.905
|
43.307 |
|
Total
Current Assets |
1252.039
|
666.019 |
423.311
|
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
1200.740
|
624.265
|
397.079 |
|
|
Provisions |
20.077
|
20.816
|
9.692 |
|
Total
Current Liabilities |
1220.817
|
645.081 |
406.771 |
|
|
Net Current Assets |
31.222
|
20.938 |
16.540 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.021 |
0.025 |
|
|
|
|
|
|
|
|
TOTAL |
42.965 |
26.842 |
19.688 |
|
PROFIT & LOSS
ACCOUNT
|
PARTICULARS |
|
31.03.2007 |
31.03.2006 |
|
|
Sales Turnover |
|
2210.376 |
1338.696 |
|
|
Other Income |
|
4.578 |
5.758 |
|
|
Total Income |
|
2214.954 |
1344.454 |
|
|
|
|
|
|
|
|
Profit/(Loss) Before Tax |
|
36.100 |
27.970 |
|
|
Provision for Taxation |
|
20.558 |
20.731 |
|
|
Profit/(Loss) After Tax |
|
15.542 |
7.239 |
|
|
|
|
|
|
|
|
Earnings in Foreign Currency : |
|
162.557 |
-- |
|
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
|
Depreciation & Financial Charges |
|
4.636 |
1.257 |
|
|
Other Expenditure |
|
2174.218 |
1315.227 |
|
Total Expenditure |
|
2178.854 |
1316.484 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
PAT / Total Income |
(%) |
0.70
|
0.54 |
NA |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
1.63
|
2.09 |
NA |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
1.46
|
4.19 |
NA |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.85
|
1.05 |
NA |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
28.92
|
24.17 |
20.92 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.03
|
1.03 |
1.04 |
LOCAL AGENCY
FURTHER INFORMATION
The Registered Office of the company has been shifted from 16/1, 1st
Floor, Doctor’s Lane, Gole Market, Delhi – 110001, India to the present address
w.e.f. 01.11.2006
Bankers Charges
Report as per Registry
|
This form is for |
Modification of
charge |
|
Charge
identification number of the modified
|
10002895 |
|
Corporate
identity number of the company |
U24231DL2002PTC117553 |
|
Name of the
company |
TAKSAL PHARMA
PRIVATE LIMITED |
|
Address of the registered
office or of the principal place of
business in India of the company |
9 – 10/3 Ground Floor, Laxman House, Asaf Ali Road, New Delhi – 110002 |
|
Type of charge |
Movable Property |
|
Particular of
charge holder |
Standard Chartered Bank Narain Manzil, 23, Barakhamba Road, New Delhi – 110001, India |
|
Nature of
description of the instrument creating or modifying the charge |
Supplementary
agreement for machinery |
|
Date of
instrument Creating the charge |
30.05.2007 |
|
Amount secured by
the charge |
Rs. 81.000
Millions |
|
Brief particulars
of the principal terms an conditions and extent and operation of the charge |
Rate of Interest Rate of Interest as
may be determined by the bank from time to time. Terms of
Repayment As per agreement Margin As per agreement Extent and
Operation of the charge 100 % Others As per agreement |
|
Short particulars
of the property charged |
The whole of the fixed
assets of the borrower situated at company’s Godowns, premises, factories or
wherever else situated including its movable plant and machinery, machinery
spars, tools and accessories and other movables, both present and future |
|
Date of latest modification
prior to the present modification |
30.10.2008 |
|
Particulars of
the present modification |
Bank’s first and
exclusive charge overall present and future fixed assets already registered for
Rs. 80.000 Millions shall stands enhanced to Rs. 81.000 Millions. The Adhoc
OD Limit of Rs. 20.000 Millions has been cancelled and regular OD limit
enhanced from Rs. 60.000 Millions to Rs. 80.000 Millions and BG limit of Rs.
1.000 Million has been sanctioned. All other terms
and conditions remained unchanged. |
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is or
was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.42.72 |
|
UK Pound |
1 |
Rs.83.96 |
|
Euro |
1 |
Rs.66.90 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
6 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
6 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
54 |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|